March 22, 2017
Cerulean Pharma's stock went down after it announced its stock purchase agreement with Daré Bioscience.
March 19, 2017
Cerulean Pharma leads the list of last week's life science gainers on the NASDAQ, followed by Catalyst Pharmaceutical, Neovasc, Arbutus...
March 12, 2017
Here's a closer look at last week's top gainers.